Category: Business, Health Services

Nephrocare Health IPO: Price, GMP, Allotment, And Analysis The Nephrocare Health IPO, a Mainboard IPO worth Rs. 871.05 Cr, marks one of the most important healthcare listings of 2025. Nephrocare Health Services Ltd. is a large, full-stack dialysis care provider operating across India and select overseas markets. With an integrated care model—diagnostics, in-centre dialysis, home dialysis, mobile dialysis, pharmacy and wellness—Nephrocare has built a strong patient-centric ecosystem. The company executed 2.88 million dialysis treatments in FY25, serving over 29,000 patients—nearly 10% of India’s dialysis population. By September 30, 2025, Nephrocare had already completed 1.59 million treatments, showing strong capacity utilisation and operational expansion. Nephrocare also enjoys long-term partnerships with some of India’s most reputed hospital chains, including Max, Fortis, Wockhardt, Paras, CMRI, Jehangir Hospital and Ruby Hall Clinic, strengthening its clinical footprint.